• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性膀胱前列腺切除术后出现胫骨转移但前列腺特异性抗原(PSA)未升高。

Tibia metastasis without prostate specific antigen (PSA) increase following radical vesiculo-prostatectomy.

作者信息

Hübler J, Sükösd F, Czipri M

机构信息

Department of Urology, University Medical School, Pécs, Hungary.

出版信息

Int Urol Nephrol. 2000;32(2):281-4. doi: 10.1023/a:1007142910479.

DOI:10.1023/a:1007142910479
PMID:11229650
Abstract

OBJECTIVES

PSA is regarded as the best method in the follow-up of prostate carcinoma. After radical vesiculo-prostatectomy the prostate carcinoma seldom recurs at zero or nearly zero PSA levels.

METHODS

The authors have used PSA since 1989 and they have found only one case where metastasis in the tibia came without an increase in PSA levels.

RESULTS

Tibia metastasis showed lower tissue activity of PSA than did the primary tumor in the prostate. The authors think this explains the zero PSA level when the metastasis developed.

CONCLUSIONS

The authors think based on their case that PSA free progression prostate cacncers may cases where the metastases do not produce PSA.

摘要

目的

前列腺特异性抗原(PSA)被视为前列腺癌随访的最佳方法。根治性膀胱前列腺切除术后,前列腺癌很少在PSA水平为零或接近零的情况下复发。

方法

作者自1989年以来一直使用PSA,仅发现1例胫骨转移时PSA水平未升高的病例。

结果

胫骨转移灶的PSA组织活性低于前列腺原发肿瘤。作者认为这解释了转移发生时PSA水平为零的原因。

结论

基于他们的病例,作者认为无PSA进展的前列腺癌可能是转移灶不产生PSA的情况。

相似文献

1
Tibia metastasis without prostate specific antigen (PSA) increase following radical vesiculo-prostatectomy.根治性膀胱前列腺切除术后出现胫骨转移但前列腺特异性抗原(PSA)未升高。
Int Urol Nephrol. 2000;32(2):281-4. doi: 10.1023/a:1007142910479.
2
Undetectable serum prostate-specific antigen associated with metastatic prostate cancer: a case report and review of the literature.不可检测的血清前列腺特异性抗原与转移性前列腺癌:一例病例报告及文献复习
Am J Clin Oncol. 1998 Aug;21(4):323-6. doi: 10.1097/00000421-199808000-00001.
3
Serum prostate-specific antigen and the biologic progression of prostate cancer.血清前列腺特异性抗原与前列腺癌的生物学进展
Urology. 1995 Jul;46(1):65-70. doi: 10.1016/S0090-4295(99)80161-7.
4
Radical prostatectomy for clinical stage T3a disease.针对临床分期为T3a期疾病的根治性前列腺切除术。
Cancer. 2007 Apr 1;109(7):1273-8. doi: 10.1002/cncr.22544.
5
Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?前列腺癌根治术后切缘阳性和/或病理T3期腺癌且术后前列腺特异性抗原检测不到:是否进行放疗?
Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):674-80. doi: 10.1016/s0360-3016(01)02677-3.
6
High dose hook effect in serum total and free prostate specific antigen in a patient with metastatic prostate cancer.一名转移性前列腺癌患者血清总前列腺特异性抗原和游离前列腺特异性抗原中的高剂量钩状效应
J Urol. 2001 Jul;166(1):213.
7
Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy.术前前列腺特异性抗原(PSA)水平与耻骨后根治性前列腺切除术后生化进展间隔时间显著相关。
Urology. 2004 Oct;64(4):723-8. doi: 10.1016/j.urology.2004.05.019.
8
The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens.
Cancer. 1998 Aug 15;83(4):748-52.
9
Chromogranin A and biochemical progression-free survival in prostate adenocarcinomas submitted to radical prostatectomy.嗜铬粒蛋白A与接受根治性前列腺切除术的前列腺腺癌患者的生化无进展生存期
Endocr Relat Cancer. 2007 Sep;14(3):625-32. doi: 10.1677/ERC-07-0089.
10
Prostate specific antigen at the initial diagnosis of metastasis to bone in patients after radical prostatectomy.根治性前列腺切除术后发生骨转移患者初诊时的前列腺特异性抗原。
J Urol. 2010 Jul;184(1):157-61. doi: 10.1016/j.juro.2010.03.033. Epub 2010 May 16.

本文引用的文献

1
Distant metastasis after radical prostatectomy in patients without an elevated serum prostate specific antigen level.血清前列腺特异性抗原水平未升高的患者在前列腺癌根治术后发生远处转移。
Cancer. 1995 Dec 15;76(12):2530-4. doi: 10.1002/1097-0142(19951215)76:12<2530::aid-cncr2820761219>3.0.co;2-f.
2
Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer.前列腺特异性抗原与格里森分级:一项前列腺癌的免疫组织化学研究
J Urol. 1994 Jun;151(6):1558-64. doi: 10.1016/s0022-5347(17)35302-8.
3
Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.
解剖性根治性前列腺切除术后的血清前列腺特异抗原。约翰·霍普金斯医院10年的经验。
Urol Clin North Am. 1993 Nov;20(4):713-25.
4
Prostate specific antigen: not detectable despite tumor progression after radical prostatectomy.前列腺特异性抗原:根治性前列腺切除术后尽管肿瘤进展但仍检测不到。
J Urol. 1989 Oct;142(4):1082-4. doi: 10.1016/s0022-5347(17)38998-x.
5
Clinical use of prostate specific antigen in patients with prostate cancer.前列腺特异性抗原在前列腺癌患者中的临床应用。
J Urol. 1989 Oct;142(4):1011-7. doi: 10.1016/s0022-5347(17)38972-3.
6
Recurrent prostate cancer despite undetectable prostate specific antigen.尽管前列腺特异性抗原检测不到,但仍存在复发性前列腺癌。
J Urol. 1992 Nov;148(5):1541-2. doi: 10.1016/s0022-5347(17)36963-x.